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Abstract Mouse spermatozoa stimulated with epidermal 
growth factor (EGF) or zona pellucida (ZP) experienced 
phosphatidylinositol 4,5-bisphosphate hydrolysis, diacylglycerol 
(DAG) generation and acrosomal exocytosis. The agonists 
showed additive effects but the action of EGF is likely to be 
mediated by a distinct receptor because maximal stimulation 
achieved with EGF was enhanced further by ZP. Generation of 
DAG and exocytosis timulated by EGF were inhibited by tyr- 
phostin A48, indicating that tyrosine kinase activity mediates 
EGF action. On the other hand, pertussis toxin did not affect the 
EGF-induced formation of DAG or exocytosis, ruling out the 
involvement of sperm Grlike proteins. These results indicate that 
EGF could be an important co-factor in the initiation of exocyto- 
sis in spermatozoa. 
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I. Introduction 
Mammalian spermatozoa undergo exocytosis of the acro- 
somal granule in response to specific stimuli derived from the 
oocyte vestments [1]. It is generally believed that zona pellucida 
(ZP), the acellular oocyte coat, is the inducer of acrosomal 
exocytosis [1], with one of its glycoproteins (ZP3 in the mouse) 
being responsible for its exocytosis-inducing activity [2]. How- 
ever, recent work has suggested that a series of molecules pres- 
ent in the cumulus-oocyte complex or in the oviductal ampulla 
(the site of fertilization) could also induce xocytosis or may act 
as co-factors during the initiation or completion of this process 
[3-5]. 
Knowledge on signal transduction during acrosomal exocy- 
tosis is still fragmentary and the identity of receptor(s) mediat- 
ing the action of ZP is still unclear. One candidate for the mouse 
ZP3 receptor is a 95-kDa protein with tyrosine kinase activity 
[6], and which becomes phosphorylated upon stimulation with 
ZP [7], thus resembling growth factor eceptors [8]. Stimulation 
with ZP also triggers the activation of a pertussis toxin (PTX)- 
sensitive G-protein (G i class) [9] and one possible mechanism 
activated by these G-proteins is channel-mediated Ca 2÷ entry 
[10]. Other targets for these transducing mechanisms are pres- 
ently unknown. 
*Corresponding author. Fax: (44) (1223) 833511. 
Studies using a model system in which exocytosis triggered 
with Ca 2÷ ionophores have revealed that Ca > entry leads to an 
early and essential phosphoinositidase C (PIC)-mediated pol- 
yphosphoinositide hydrolysis [11], and a rapid phospholipase 
C-mediated breakdown of phosphatidylcholine [12], both con- 
tributing to generate 1,2-diacylglycerol (DAG) [13]. The major 
second messenger role of DAG appears to be the stimulation 
of phospholipase A 2 [14] which, in turn, would generate meta- 
bolites that directly or indirectly bring about membrane fusion 
[15,16]. Although this latter work has highlighted the apparent 
central role of DAG in events downstream of Ca 2+ entry, the 
links between these and events upstream of Ca 2+ influx are not 
well understood. 
Recent studies have revealed that epidermal growth factor 
(EGF) can induce [17] or enhance [18] acrosomal exocytosis, 
which raises the possibility that this growth factor may have a 
role in sperm activation at fertilization. An EGF receptor has 
been identified in spermatozoa from various species [17,19,20] 
and, moreover, it has been found that the receptor becomes 
phosphorylated upon exposure to EGF [19]. However, the gen- 
eration of second messengers elicited by EGF has not been 
investigated. Here we report that stimulation of capacitated 
mouse spermatozoa with EGF leads to generation of second 
messenger DAG and acrosomal exocytosis by a signalling cas- 
cade involving protein tyrosine kinase. 
2. Materials and methods 
2.1. Materials 
[32PIP i (carrier-free; 10 mCi/ml) was from Amersham International 
(Amersham, Bucks., UK). Mouse EGF was kindly provided by Dr. 
K.D. Brown of this Institute. Pertussis toxin was from RBI-Semat (St. 
Albans, Herts, UK). 1,2-Dioleoyl-sn-glycerol, chlortetracycline, and 
bovine serum albumin (Fraction V) were from Sigma Chemical Co. 
(Poole, Dorset, UK). Tyrphostin A48 was from LC Laboratories (Not- 
tingham, UK). Thin layer chromatography plates were from E. Merck 
(Darmstadt, Germany). All the chemicals u ed were of analytical grade 
(BDH, Poole, Dorset, UK). Organic solvents were from BDH or Fisons 
(Loughborogh, Leics, UK). 
2.2. Media 
The medium used for incubation of spermatozoa was a modified 
Tyrode's olution (mT-B25) with 5.56 mM glucose and 4 mg bovine 
serum albumin/ml [21]; it was maintained inequilibrium with 5% CO2 
in air (pH 7.4 at 37°C; measured osmolality: 295 mOsm/kg). A HEPES- 
buffered medium (mT-H) was also used. It contained 20 mM HEPES 
in place of the NaHCO3, and the concentration f NaC1 was ajusted 
to give the same final osmolality. The pH was adjusted to 7.4 with 
NaOH, and was used under air. 
Abbreviations: ZP, zona pellucida; PTX, pertussis toxin; PIC, phospho- 
inositidase C;DAG, 1,2-diacylglycerol; EGF, epidermal growth factor; 
PtdIns(4,5)P> phosphatidylinositol 4,5-bisphosphate. 
2.3. Preparation of ZP 
Zonae pellucidae were collected and solubilized as described previ- 
ously [7,9]. Briefly, ovaries were isolated from outbred female mice 
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(21-23 days old) of the TO strain and were homogenized in the HB 
buffer solution [22]. The homogenate was then loaded onto a two-step 
gradient of Percoll/HB buffer (10% and 20%, v/v), each with 0.2% (w/v) 
poly(vinylalcohol), and centrifuged for 10 min at 800 × gm~x at room 
temperature. The layer with ZP was recovered and washed twice with 
HB buffer; ZP were stored at -80°C until use. When required, ZP were 
solubilized by heating at 60°C for 1 h. 
2.4. Preparation and treatment of spermatozoa 
Spermatozoa were obtained from the caudae pididymides and vasa 
deferentia of outbred male TO mice (> 40 g) and were incubated in 
mT-B25 in culture dishes under liquid paraffin for 1.5 h at 37°C (gas 
phase: 5% CO2 in air); sperm concentrations were 3-7 × 106 cells/ml and 
motility >75%. Agonists (EGF and/or ZP) were then added and incuba- 
tions continued for 15 min under 5% CO2 in air. The effects of putative 
inhibitors were examined by adding them (or their solvents as controls) 
15 min prior to the addition of agonists. At the end of incubations, cells 
were stained with chlortetracycline and categorized into 3 groups [23]: 
'F' pattern (uncapacitated), 'B'pattern (capacitated, acrosome-intact), 
and 'AR' pattern (cells that have undergone acrosomal exocytosis). 
To study changes in sperm lipids, cells incubated in mT-B25 in plastic 
tubes (30 x 115 mm) for 1.5 h at 37°C under 5% CO2/air (sperm concen- 
tration ~ 1 x 107 cells/ml) were diluted 1:1 (v/v) with mT-H and centri- 
fuged at 600 x gmax for 10 min at room temperature. The supernatant 
was removed and cells were resuspended in mT-H (concentration: 
~5 × 107 cells/ml). Cell stimulation was carried out by incubation 
with the agonists at 37°C under air. When 32p-labelled cells were re- 
quired, spermatozoa were incubated in mT-B25 with 150/zCi [32p]Pi/ml 
under 5% CO2 in air for 1.5 h, and then washed and resuspended in 
mT-H medium (concentration: ~2 × 107 cells/ml). To test the effect of 
putative inhibitors, spermatozoa were preincubated in mT-B25 for 1 h, 
washed as described, and were resuspended in mT-H medium. Inhib- 
itors were added and spermatozoa were incubated for 15 min under air 
before exposure to agonists. 
2.5. Lipid analyses 
To measure changes in 32p-labelled phosphoinositides, sperm lipids 
were extracted 5 min after stimulation, and were separated and quanti- 
fied as reported previously [15]. Briefly, after extraction, lipids were 
separated by t.l.c, using the solvent system chloroform/methanol/water/ 
concentrated NH3 (38 : 40 : 5 : 5, v/v) [24]. Lipid spots were made visible 
by autoradiography, identified by using the autoradiographs a tem- 
plates, scraped off, and the radioactivity in each was determined by 
liquid scintillation counting. 
For quantification of DAG mass, reactions were stopped by adding 
chloroform/methanol (1:2, v/v) 2.5 min after stimulation, and lipids 
were then extracted according to Bligh and Dyer [25]. Neutral ipids 
were separated by t.l.c, using the solvent system chloroform/methanol/ 
acetic acid (98:2:1, v/v) [12,26]. 1,2-Diacylglycerol was quantified by 
Coomassie blue staining [27] and densitometry, using 1,2-dioleoyl-sn- 
glycerol to construct standard curves for each plate [13,28]. 
2.6. Statistics 
Results are means + S.E.M. Percentages ofcells undergoing exocyto- 
sis, and DAG mass, were transformed to arcsin ~/(% 'AR' cells+100), 
or log10 (fig/109 spermatozoa), respectively, and data were analysed 
using Student's t-test. Values of P < 0.05 were regarded as statistically 
significant. 
3. Resul ts  
Mouse spermatozoa capacitated for 1.5 h in mT-B25 medium 
and stimulated with EGF  for 15 min underwent acrosomal 
exocytosis, as revealed by the increase in the proportion of cells 
exhibiting an 'AR'  pattern (Fig. 1A); the effect was concentra- 
tion-dependent and was maximal at 100 ng/ml. EGF  did not 
impair sperm motility. Spermatozoa capacitated in a similar 
way and exposed to 1 ZP//A for 15 min also underwent exocy- 
tosis (Fig. 1A). Exposure of capacitated spermatozoa to half- 
maximal concentrations of both agonists (0.1 ng EGF/ml and 
0.5 ZP/~I) revealed additive ffects (Fig. lb). However, since the 
effect seen with maximal concentrations of EGF  (100 ng/ml) 
was enhanced further by inclusion of 0.5 ZP//zl (Fig. 1B) or 
1 ZP//A (Fig. 1C), it is likely that both agonists act on separate 
receptors. 
When mouse spermatozoa were capacitated in mT-B25 me- 
dium in the presence of 150/zCi [32p]Pi/ml to label the phospho- 
inositides, washed, resuspended in mT-H medium and stimu- 
lated with 100 ng EGF/ml for 5 min, breakdown of phosphat- 
idylinositol 4,5-bisphosphate (Ptdlns(4,5)P2) was revealed (Fig. 
2A); spermatozoa stimulated with 1 ZP//zl for 5 min also expe- 
rienced breakdown of Ptdlns(4,5)P2. In parallel experiments, 
unlabelled spermatozoa were similarly treated and DAG mass 
measured after 2.5 min (when DAG levels are maximal; data 
not shown). Stimulation with 100 ng EGF/ml resulted in a 
considerable generation of DAG and similar results were ob- 
tained after stimulation with 1 ZP//tl (Fig. 2B). These results 
confirm that hydrolysis of Ptdlns(4,5)P2 by PIC is taking place 
(cf. [12]) after EGF  and ZP stimulation and, since the mass of 
polyphosphoinositides in sperm membranes is small [29,30], 
suggest hat hydrolysis of phosphatidylcholine by phospholip- 
ase C contributes ubstantially to the DAG pool. 
To investigate if the action of EGF  is related to protein 
tyrosine phosphorylation, the effects of tyrphostin A48 were 
examined. Capacitated mouse spermatozoa were exposed to 
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Fig. 1. Effect of EGF and/or ZP on mouse sperm acrosomal exocytosis. Capacitated spermatozoa were exposed to agonists for 15 min, and were 
then stained with chlortetracycline and examined for exocytosis (% 'AR' pattern). (A) Effect of different concentrations of EGF or 1 ZP//zl (n = 3); 
a: different from control (P < 0.01). (B) Effect of simultaneous exposure to 0.1 ng EGF/ml and 0.5 ZP//.tl, or 100 ng EGF/ml and 0.5 ZP//zl (n = 3); 
a: different from control (P --- 0.001); b: different from 0.5 ZP//.tl or 0.1 ng EGF/ml (P <- 0.004); c, different from 0.5 ZP//zl or 100 ng EGF/ml. (C). 
Effect of exposure to 100 ng EGF/ml and 1 ZP//tl (n = 4); a: different from control (P -< 0.003); b: different from 1 ZP/pl or 100 ng EGF/ml (P -< 0,04). 
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Fig. 2. Effect of EGF and ZP on PtdIns(4,5)P2 hydrolysis and DAG generation i  mouse spermatozoa. (A) Spermatozoa c pacitated in mT-B25 
for 1.5 h in the presence of 150/zCi [32p]Pi/ml were washed, resuspended in mT-H medium and stimulated with EGF (100 ng/ml) or 1 ZP//zl for 5 min. 
Lipids were extracted, separated and radioactivity in each spot counted (n -- 4); a,b: different from control (P < 0.01 and P = 0.02, respectively). 
(B) Spermatozoa c pacitated for 1.5 h were washed, resuspended, and stimulated with EGF (100 ng/ml) or 1 ZP/pl for 2.5 min. Lipids were extracted, 
separated and DAG mass was quantified by Coomassie blue staining and densitometry (n = 3); a: different from control (P < 0.05). 
A48 for 15 rain before agonist addition, and DAG mass and 
% 'AR' cells (indicative of exocytosis) were quantified. The 
ability of EGF (100 ng/ml) to induce either formation of DAG 
or exocytosis was prevented by A48 in a concentration-depend- 
ent manner (Fig. 3A,B). The concentration of A48 (12.5 pM) 
that completely blocked DAG generation and exocytosis in- 
duced by EGF also blocked the formation of DAG and exocy- 
tosis elicited by ZP (data not shown); A48 (or its DMSO sol- 
vent) did not affect sperm motility or cell integrity (data not 
shown). 
To test if EGF action is related to activation of sperm Gi-like 
proteins [9], the effect of pertussis toxin (PTX) was examined. 
Concentrations of up to 1 gg PTX/ml did not affect the ability 
of EGF (100 ng/ml) to stimulate DAG formation (Fig. 3A) or 
exocytosis (Fig. 3B), although at 1 /zg/ml it did inhibit the 
ZP-induced generation of DAG (93% inhibition) and exocyto- 
sis (87% inhibition) (not shown). PTX alone (up to 1/.tg/ml) did 
not affect cell motility or integrity, and did not induce exocyto- 
sis (data not shown). 
4. Discussion 
The results of this study clearly demonstrate hat EGF in- 
duces generation of DAG and acrosomal exocytosis in mouse 
spermatozoa nd that protein tyrosine kinase activation is 
likely to be a fundamental event in the signalling pathway 
evoked by this agonist. 
The action of EGF does not appear to be mediated by a 
receptor targeted by ZP/ZP3 but by a separate receptor. Previ- 
ous work [6,7] has hinted similarities between a sperm 95-kDa 
protein, presumed to be a ZP3 receptor, and growth factor 
receptors, because the former has intrinsic tyrosine kinase ac- 
tivity and may be autophosphorylated upon stimulation with 
ZR However, this 95-kDa protein has recently been found to 
be a unique hexokinase that is phosphorylated on tyrosine 
residues [31]. On the other hand, recent studies have shown the 
existence of a distinct 170-kDa EGF receptor in spermatozoa 
from various species, including the mouse [17,19,20], and that 
this receptor is phosphorylated upon exposure to EGF [19]. 
The results presented here agree with the idea that EGF acts 
on a distinct receptor, because cell responses evoked with max- 
imal concentrations of EGF were enhanced further by stimula- 
tion with ZR 
Growth factor actions on somatic cells are transduced by 
receptors with tryrosine kinase activity [8]. Our results indicate 
that tyrosine kinase activity of the sperm EGF receptor is 
essential for the activation of downstream processes, uch as 
DAG generation and subsequent exocytosis, because treatment 
with tyrphostin A48, a tyrosine kinase inhibitor, blocked EGF- 
induced responses. 
On the other hand, EGF receptors appear to be coupled to 
PTX-sensitive Gi proteins in some cells [32]. We have therefore 
examined whether sperm PTX-sensitive Gi proteins [9] are in- 
volved in EGF action. We found that PTX was unable to 
interfere with DAG formation or exocytosis triggered by EGF. 
Failure to reveal PTX inhibition of acrosomal exocytosis trig- 
gered by progesterone [33], another agonist of acrosomal ex- 
ocytosis [3], has been criticised on the grounds that evidence for 
sufficient inactivation of G-proteins had not been demon- 
strated [34]. Although direct inactivation of Gi proteins was not 
examined in our study, we believe our results are meaningful 
because in parallel experiments, using identical conditions, 
PTX was found to inhibit significantly the formation of DAG 
and exocytosis evoked by ZP (cf. [35], for exocytosis). 
Stimulation of spermatozoa with EGF resulted in hydrolysis 
of PtdIns(4,5)P> It is therefore possible that the sperm EGF 
receptor is coupled to a PIC. No information exists on the 
possible classes of PICs present in spermatozoa but, based on 
information of EGF-activated pathways in somatic ells [36], 
it is possible that a sperm PIC-),I is being activated. It is inter- 
esting to mention in this context hat sperm PIC activation and 
PtdIns(4,5)P2 hydrolysis appear to take place only after Ca z+ 
entry [11,37,38]. Thus, it would be important to clarify whether 
the EGF-induced PtdIns(4,5)P2 breakdown observed in this 
study is due to a PIC directly coupled to the EGF receptor or 
whether this receptor and its tyrosine kinase activity are linked 
to an early Ca 2+ entry preceding and leading to PIC acti- 
vation. 
The mass of DAG generated after EGF stimulation exceeds 
that potentially arising via PtdIns(4,5)P2 breakdown, so it is 
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Fig. 3. Effect of tyrphostin A48 and pertussis toxin (PTX) on DAG generation and acrosomal exocytosis triggered by EGF in mouse spermatozoa. 
(A) DAG generation. Spermatozoa were capacitated in mT-B25 for 1 h, washed, resuspended in mT-H medium and exposed to A48 or PTX for 
15 min before addition of EGF (100 ng/ml). Lipids were extracted 2.5 min after EGF, separated, and DAG quantified by Coomassie blue staining 
and densitometry (n= 3); a: different from control (P < 0.05); b: different from EGF (P < 0.05). (B) Acrosomal exocytosis. Spermatozoa were 
capacitated for 1.5 h in mT-B25; A48 or PTX were added for the last 15 min of capacitation. Cells were then stimulated with EGF for 15 rain, stained 
with chlortetracycline and examined for exocytosis (% 'AR' pattern) (n = 3); a: different from control (P < 0.05); b: different from EGF (P < 0.05). 
most likely that a phosphatidylcholine-specific phospholipase 
C is being activated in parallel to PIC or, perhaps, by 
PtdIns(4,5)P2-derived DAG (cf. [12]). Activation ofa phosphat- 
idylcholine-phospholipase C in the absence of PlC-mediated 
PtdIns(4,5)P2 breakdown has been found in several somatic ell 
systems after EGF stimulation ([39] and references therein), but 
it is not known whether such phospholipase C is directly cou- 
pled to the EGF receptor or whether there are other kinases 
involved in a phosphorylation cascade [40]. Therefore, the 
mechanism regulating the activation of sperm phospholipase C 
after EGF stimulation deserves further attention. 
In conclusion, it is likely that EGF plays a significant role in 
the initiation of acrosomal exocytosis under physiological con- 
ditions. This growth factor is present in the oviduct [41,42] and 
could be present in the oocyte itself [20]. Concentrations of
EGF even lower than those present in the oviduct [43] were able 
to enhance acrosomal exocytosis timulated by ZP, the agonist 
believed to be the main inducer of exocytosis in this cell [1,34]. 
Thus, EGF  could be an important co-factor during sperm acti- 
vation at fertilization. 
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